Development of therapeutic peptides to treat bacterial and viral infections

Peptide therapeutics are a novel approach to treat bacterial and viral infections, which have major advantages over small molecules. Peptide molecules have been used previously to treat HIV infections, and I have previously shown that peptide molecules targeting Chlamydia can prevent infection in vivo. Project Objectives: 1. To take previously characterized peptides, move them onto an HSA scaffold, and evaluate their expression in a yeast system. 2. To test the HSA scaffold therapeutic peptides in vitro against Chlamydia infection, RSV infection, and influenza infection. 3. To modify the peptides based on crystal structures of the target proteins and optimize their target specificity.

Intern: 
Christopher Stone
Superviseur universitaire: 
Dr. William Sheffield
Project Year: 
2014
Province: 
Ontario
Université: 
Discipline: 
Programme: